| Margaret Tryon, LCPC | |
|
704 N 30th St, Billings, MT 59101-0913 | |
| (406) 259-8800 | |
| (406) 259-4400 |
| Full Name | Margaret Tryon |
|---|---|
| Gender | Female |
| Speciality | Counselor - Professional |
| Location | 704 N 30th St, Billings, Montana |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1265808836 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 101YP2500X | Counselor - Professional | (* (Not Available)) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Margaret Tryon, LCPC 2407 Golden Blvd, Billings, MT 59102-1209 Ph: (406) 656-6308 | Margaret Tryon, LCPC 704 N 30th St, Billings, MT 59101-0913 Ph: (406) 259-8800 |
News Archive
A team of scientists in the United States recently estimated the risk of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) transmission from primary cases to household contacts.
Mindray Medical International Limited, a leading developer, manufacturer and marketer of medical devices worldwide, announced today its selected unaudited financial results for the fourth quarter and full year ended December 31, 2012.
The recent launch of two clinical trials offer innovative study designs for patients with lung cancer. These clinical trials are the direct result of a National Cancer Institute sponsored workshop chaired by Drs. Fred R. Hirsch, Shakun Malik and Claudio Dansky- Ullman, that brought together the NCI Thoracic Malignancies Steering Committee, the US Food and Drug Administration, academicians, clinicians as well as industry and government stakeholders to discuss issues and challenges related to clinical trial design and biomarkers for lung cancer targeted-therapies.
Alkermes, Inc. today announced that the U.S. Food and Drug Administration (FDA) has notified the company of the tentative scheduling of a Psychopharmacologic Drugs Advisory Committee meeting on September 16, 2010, for the review of the company's supplemental New Drug Application (sNDA) for VIVITROL® (naltrexone for extended-release injectable suspension) for opioid dependence.
› Verified 9 days ago
Mrs. Jennipher Kay Doyle, M.S. Counselor Medicare: Not Enrolled in Medicare Practice Location: 3286 Granger Ave E, #8, Billings, MT 59102 Phone: 406-534-1275 | |
Mrs. Lital Diament, LMFT Counselor Medicare: Not Enrolled in Medicare Practice Location: 8270 Pond Rd, Billings, MT 59106 Phone: 406-697-6165 Fax: 805-552-4551 | |
Amie Laurayne Havner, MS, LCPC Counselor Medicare: Not Enrolled in Medicare Practice Location: 1411 Main St Ste B-c, Billings, MT 59105 Phone: 406-969-5183 Fax: 406-281-8308 | |
Katy Allyn Schwenneker, LCPC Counselor Medicare: Not Enrolled in Medicare Practice Location: 510 N 29th St Ste 206, Billings, MT 59101 Phone: 406-312-6067 | |
Mrs. Cassandra Jean Cates, LAC Counselor Medicare: Not Enrolled in Medicare Practice Location: 1231 N 29th St, Billings, MT 59101 Phone: 406-248-3175 | |
Sheryl M. Whiteman, LAC Counselor Medicare: Not Enrolled in Medicare Practice Location: 208 N 29th St Ste 215, Billings, MT 59101 Phone: 406-998-7962 Fax: 406-998-7962 | |
Linda F Rykowski, L.C.P.C. Counselor Medicare: Not Enrolled in Medicare Practice Location: 1629 Avenue D, Suite 2a Bldg B, Billings, MT 59102 Phone: 406-670-9410 Fax: 406-252-8898 |